Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-02

Clinical Trial Update: Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration [NA]

View source ↗

Summary

A completed feasibility study assessing the use of the PRIMA System to compensate for blindness in patients with dry age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Science Corporation | Conditions: Dry Age-related Macular Degeneration | NA | Status: COMPLETED